Brief: Mendus Announces Agreement With Olivia Newton-John Cancer Research Institute
23/03/2026 07:32
March 23 (Reuters) - Mendus AB (publ) IMMUN.ST: ANNOUNCES AGREEMENT WITH OLIVIA NEWTON-JOHN CANCER RESEARCH INSTITUTE FOR DIVA STUDY IN AML DIVA STUDY TO EVALUATE VIDIDENCEL IN NEWLY DIAGNOSED AML PATIENTS TREATED WITH VENETOCLAX AND AZACITIDINE Source text: ID:nMFNY3Gs8 Further company coverage: IMMUN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))